MaaT Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	100	77	111	81	79	132
Market Cap Growth	5.53%	-29.96%	36.57%	2.32%	-40.01%	-
Enterprise Value	92	77	97	59	49	123
Last Close Price	5.30	4.81	7.96	6.98	8.00	13.35
PS Ratio	22.08	17.12	34.39	36.35	55.35	135.75
PB Ratio	55.51	43.06	10.70	3.96	2.95	3.31
P/TBV Ratio	-	-	12.91	4.24	3.09	3.38
EV/Sales Ratio	20.43	16.98	30.05	26.41	34.22	126.09
Debt / Equity Ratio	9.69	9.69	1.54	0.69	0.42	0.15
Net Debt / Equity Ratio	-4.13	-4.13	-0.41	-0.50	-0.89	-0.94
Net Debt / EBITDA Ratio	0.25	0.25	0.15	0.52	1.80	4.30
Net Debt / FCF Ratio	0.46	0.46	0.18	0.52	1.81	4.59
Asset Turnover	0.11	0.11	0.08	0.05	0.03	0.03
Inventory Turnover	23.35	23.35	12.71	7.41	16.05	-
Quick Ratio	1.87	1.87	1.81	2.65	4.38	9.93
Current Ratio	1.94	1.94	1.90	2.78	4.57	10.05
Return on Equity (ROE)	-511.92%	-511.92%	-187.68%	-83.41%	-41.14%	-32.33%
Return on Assets (ROA)	-44.75%	-44.75%	-43.64%	-28.44%	-18.00%	-15.08%
Return on Capital Employed (ROCE)	-107.80%	-107.80%	-118.70%	-63.50%	-38.20%	-19.90%
Earnings Yield	-31.10%	-40.10%	-26.13%	-24.34%	-17.32%	-6.83%
FCF Yield	-16.35%	-21.07%	-20.61%	-24.40%	-16.76%	-6.19%
Buyback Yield / Dilution	-21.97%	-21.97%	-14.95%	-14.89%	-307.65%	-135.06%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.